August Troendle

$2.77B
as of 10/04/24

About August Troendle

August Troendle is the CEO of Medpace, a clinical research company he founded in Cincinnati, Ohio in 1992; he owns about 19% of the stock.

Medpace conducts clinical trials for pharmaceutical companies seeking to bring drugs, vaccines or medical devices to market.

Before starting Medpace, Troendle spent five years as a director at Swiss pharma company Sandoz, now known as Novartis.

He also briefly worked as a medical review officer at the FDA's division of metabolic and endocrine drug products from 1986 to 1987.

A doctor with an M.D. from the University of Maryland, Troendle has also served on the boards of several public and private healthcare companies.

Personal stats

Citizenship

United States of America

Source of wealth

Pharmaceutical services

Residence

Cincinnati, Ohio

Birth date

01/01/56 (age 68)

Education

Medical Doctor, University of Maryland

Self-made

self-made

August Troendle’s fortune is worth

46K

troy ounces of gold

43K

median U.S. household

28K

median U.S. income

0.055%

U.S. credit card volume

0.011%

GDP of the United States

0.008%

United States debt

Net worth history

Annual ranking

Net worth over time

Real-time ranking

Financial assets

NASDAQ | MEDP-US

Medpace

NASDAQ | MEDP-US

Medpace

NASDAQ | MEDP-US

Medpace

NASDAQ | MEDP-US

Medpace

NASDAQ | MEDP-US

Medpace

NASDAQ | MEDP-US

Medpace

NASDAQ | MEDP-US

Medpace

Images © Forbes.com. All rights reserved.